Clinical trial
A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus…
NCT00377637 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00377637 |
|---|---|
| Title | A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis. |
| Official title | A Prospective, Randomized, Active Controlled, Parallel Group, Multi-center Trial to Assess the Efficacy and Safety of Mycophenolate Mofetil (MMF) in Inducing Response and Maintaining Remission in Subjects With Lupus Nephritis. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Collaborators | Aspreva Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lupus Nephritis |
| Intervention type | Drug |
| Interventions | Mycophenolate mofetil (MMF), Cyclophosphamide, Azathioprine, Placebo to Azathioprine, Placebo to Mycophenolate mofetil, Corticosteroid |
| Enrollment | 370 |
| Start date | Jul 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2010 |
| First posted | Sep 18, 2006 |
| Last update posted | Dec 6, 2011 |
| Countries | Argentina, Australia, Belgium, Brazil, Canada, China, Czechia, France, Germany, Greece, Hungary, Italy and 5 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: